Detalhe da pesquisa
1.
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
HIV Med
; 22(7): 567-580, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792134
2.
HIV MDR is still a relevant issue despite its dramatic drop over the years.
J Antimicrob Chemother
; 75(5): 1301-1310, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31976521
3.
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen.
J Antimicrob Chemother
; 72(3): 855-865, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27999048
4.
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
J Antimicrob Chemother
; 72(10): 2837-2845, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091206
5.
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
HIV Med
; 18(1): 21-32, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27353061
6.
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
J Antimicrob Chemother
; 71(3): 739-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26679249
7.
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
J Antimicrob Chemother
; 70(6): 1865-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712318
8.
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
HIV Med
; 16(5): 297-306, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585664
9.
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.
J Viral Hepat
; 22(5): 469-80, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311757
10.
Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors.
Antimicrob Agents Chemother
; 58(5): 2781-97, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24590484
11.
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.
Infection
; 42(1): 61-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24146352
12.
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
HIV Med
; 14(9): 571-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23668660
13.
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals.
J Clin Virol
; 168: 105551, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573167
14.
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy.
J Hosp Infect
; 115: 51-58, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171407
15.
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
Infection
; 37(3): 203-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19274429
16.
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.
Infection
; 37(3): 233-43, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19169632
17.
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Clin Microbiol Infect
; 25(7): 906.e1-906.e7, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30472417
18.
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis.
J Clin Virol
; 106: 49-52, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30075459
19.
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life.
Clin Microbiol Infect
; 23(10): 777.e1-777.e4, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412381
20.
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Clin Microbiol Infect
; 22(2): 191-200, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482266